This was validated at the protein level both in vitro and clinically by demonstrating that RASGRF2 protein was highly expressed in three STAD-relevant cell lines (relative to a normal gastric cell line) and in tumor relative to adjacent non-tumor tissue in an independent STAD cohort. The gene discussed is RASGRF2; the disease is neoplasm.